Qianjiang Yongan Pharmaceutical Co Ltd
Qianjiang Yongan Pharmaceutical Co., Ltd. engages in production and sale of taurine in China. It produces ethylene oxide, polycarboxylic acid-based water reducer monomers, water reducers, and health products. The company engages in scientific research and technical service, creatine monohydrate, wholesale and retail trade, leasing and business services, and crop farming. Qianjiang Yongan Pharmace… Read more
Qianjiang Yongan Pharmaceutical Co Ltd (002365) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.029x
Based on the latest financial reports, Qianjiang Yongan Pharmaceutical Co Ltd (002365) has a cash flow conversion efficiency ratio of 0.029x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥58.18 Million) by net assets (CN¥2.02 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Qianjiang Yongan Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2006–2024)
This chart illustrates how Qianjiang Yongan Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Qianjiang Yongan Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Qianjiang Yongan Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Kaleseramik Canakkale Kalebodur Seramik Sanayi A.S.
IS:KLSER
|
-0.070x |
|
TSE Co. Ltd
KQ:131290
|
0.078x |
|
Raydium Semi-Conductor
TW:3592
|
0.055x |
|
RLH Properties S.A.B. de C.V
MX:RLHA
|
0.028x |
|
Impulse Qingdao Health Tech Co Ltd
SHE:002899
|
0.036x |
|
Gladstone Land Corporation
NASDAQ:LAND
|
-0.018x |
|
Dioo Microcircuits Co. Ltd. Jiangsu A
SHG:688381
|
N/A |
|
Anshan Senyuan Road Bridge
SHE:300210
|
0.026x |
Annual Cash Flow Conversion Efficiency for Qianjiang Yongan Pharmaceutical Co Ltd (2006–2024)
The table below shows the annual cash flow conversion efficiency of Qianjiang Yongan Pharmaceutical Co Ltd from 2006 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.04 Billion | CN¥105.71 Million | 0.052x | -56.59% |
| 2023-12-31 | CN¥2.05 Billion | CN¥244.26 Million | 0.119x | -35.25% |
| 2022-12-31 | CN¥2.10 Billion | CN¥387.28 Million | 0.184x | +253.98% |
| 2021-12-31 | CN¥1.96 Billion | CN¥101.81 Million | 0.052x | -54.34% |
| 2020-12-31 | CN¥1.81 Billion | CN¥206.66 Million | 0.114x | -21.20% |
| 2019-12-31 | CN¥1.66 Billion | CN¥239.55 Million | 0.145x | -26.06% |
| 2018-12-31 | CN¥1.61 Billion | CN¥314.02 Million | 0.196x | +33.26% |
| 2017-12-31 | CN¥1.34 Billion | CN¥197.32 Million | 0.147x | +104.33% |
| 2016-12-31 | CN¥1.18 Billion | CN¥84.53 Million | 0.072x | +13.87% |
| 2015-12-31 | CN¥1.12 Billion | CN¥70.61 Million | 0.063x | +262.73% |
| 2014-12-31 | CN¥1.11 Billion | CN¥19.26 Million | 0.017x | -70.50% |
| 2013-12-31 | CN¥1.08 Billion | CN¥63.65 Million | 0.059x | -8.84% |
| 2012-12-31 | CN¥1.09 Billion | CN¥70.75 Million | 0.065x | -25.14% |
| 2011-12-31 | CN¥1.06 Billion | CN¥91.23 Million | 0.086x | +98.86% |
| 2010-12-31 | CN¥1.01 Billion | CN¥44.06 Million | 0.043x | -61.35% |
| 2009-12-31 | CN¥324.17 Million | CN¥36.43 Million | 0.112x | -81.62% |
| 2008-12-31 | CN¥259.12 Million | CN¥158.47 Million | 0.612x | +91.78% |
| 2007-12-31 | CN¥191.53 Million | CN¥61.08 Million | 0.319x | +7.60% |
| 2006-12-31 | CN¥104.99 Million | CN¥31.11 Million | 0.296x | -- |